Dormicum®

Dormicum^® 7,5 mg midazolam film-coated tablets.

Dormicum^® tablets: White, biconvex, oval shaped, debossed 7.5 on one side and scored on the other.

Posology

Orally. Dosage range: 7.5 – 15 mg per day.

The duration of treatment should be as short as possible. In general, the duration of treatment varies from few days to a maximum of 2 weeks.

Treatment should be started with the minimum recommended dose. The maximum dose should never be exceeded because it increases the risk of CNS adverse reactions, probably including depression.

The dose reduction process should be adjusted for each patient. Dormicum^® treatment should not be stopped abruptly.

• Elderly patients
  The recommended dose in elderly and / or debilitated patients is 7.5 mg per day.
• Patients with liver failure
  Patients with severe liver failure should not be treated, from mild to moderate the lowest possible dose should be considered, not exceeding 7.5 mg.
• Patients with kidney failure
  The lowest possible dose should be considered, not exceeding 7.5 mg.
• Pediatric population
  Dormicum^® tablets should not be administered to children 12 years of age or younger because the dose of the tablets does not allow an appropriate dosage for this patient population.

Method of administration

Tablets should be swallowed whole with some liquid.
Dormicum^® can be taken at any time of the day, ensuring that the patient can get at least 7-8 hours of sleep undisturbed.

Ownership : CHEPLAPHARM Arzneimittel GmbH

Comercialized by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative.